文献速递生殖医学

hCG触发后IVF患者早期黄体期激素谱研究

The early luteal hormonal profile in IVF patients triggered with hCG.
PubMed 文献 · Hum Reprod · 2020-01-01

本研究前瞻性纳入161名正常卵巢储备的IVF患者,采用GnRH拮抗剂方案和hCG触发,全胚冷冻且无黄体支持。结果显示孕酮在取卵后第4天达峰(114 ng/mL),约三分之二患者取卵后第4至6天孕酮下降,hCG前及hCG后12小时孕酮水平可预测早期黄体期水平。

要点

  • 孕酮在取卵后第4天达峰,平均约114 ng/mL。
  • 约三分之二患者取卵后第4至6天孕酮下降。
  • hCG前孕酮可预测早期黄体期孕酮水平。

核心结论

  • hCG触发后早期黄体期孕酮在取卵后第4天达峰,随后部分患者下降。
  • hCG前及hCG后12小时孕酮水平可预测早期黄体期孕酮水平。

研究设计与样本

  • 前瞻性研究,纳入161名正常卵巢储备的IVF女性,最终分析160名。
  • 采用GnRH拮抗剂方案和FSH刺激,hCG 250 μg触发,全胚冷冻无黄体支持。

主要发现

  • 孕酮在取卵后第1天开始上升,取卵后第4天达峰(114 ng/mL),取卵后第5天起下降。
  • 孕酮峰值在取卵后第4、5、6天者分别占38.8%、29.4%、13.8%。
  • 约三分之二患者取卵后第4至6天孕酮下降。
  • hCG前孕酮与hCG后24小时孕酮显著相关(r2=0.28;P<0.001),后者与取卵后第4天孕酮显著相关(r2=0.32;P<0.001)。
  • LH在hCG触发后12小时达峰(4.4 IU/L),持续24小时但较生理水平 barely elevated;雌二醇在触发后24小时和取卵后第4天出现双峰;hCG在注射后24小时达最高(130 mIU/mL)。

临床怎么用

  • 详细早期黄体期激素谱可用于优化和个体化黄体期支持以改善生殖结局。

局限性

  • 全胚冷冻策略无法确定孕酮谱对生殖结局的影响。
  • 缺乏子宫内膜组织学或容受性分析数据,无法明确血清激素与种植窗的关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the early luteal phase hormonal profile in patients undergoing ovarian stimulation for IVF/ICSI followed by hCG trigger and a freeze-all strategy without luteal phase support? SUMMARY ANSWER: The peak concentration of progesterone occurred 4 days after oocyte pick-up (OPU + 4), with an average 35% fall from OPU + 4 to OPU + 6, and progesterone levels before and 12 h after hCG administration predicted levels during the early luteal phase. WHAT IS KNOWN ALREADY: The luteal phase during IVF differs from that during normal cycles, particularly with respect to the serum progesterone level profile. This can cause asynchrony between the embryo and the endometrium, potentially resulting in implantation failure and poor reproductive outcomes. STUDY DESIGN, SIZE, DURATION: This prospective study included 161 women with normal ovarian reserve receiving GnRH antagonist co-treatment during ovarian stimulation with FSH who were followed up to 6 days after OPU in a single IVF cycle. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women aged 18-42 years undergoing IVF with ovarian stimulation using FSH were included. Ovulation was triggered with recombinant hCG 250 μg. Hormone levels were determined from blood samples taken on the day of trigger, before hCG, at 12, 24 and 36 h after hCG and at 1, 2, 3, 4, 5 and 6 days after OPU. The primary endpoint was early luteal phase serum concentrations of progesterone, LH, estradiol and hCG. MAIN RESULTS AND THE ROLE OF CHANCE: One outlier with a pre-hCG serum progesterone level of 11.42 ng/mL was excluded, so all analyses included 160 subjects. Progesterone levels began to increase 1 day after OPU, peaked 4 days after OPU (114 ng/mL), then declined from OPU + 5 onwards. Peak progesterone levels were at OPU + 4, OPU + 5 or OPU + 6 in 38.8, 29.4 and 13.8% of patients, respectively. Approximately two-thirds of patients had a fall in serum progesterone from OPU + 4 to OPU + 6. Pre-hCG progesterone levels correlated significantly with those at 24 h after hCG (r2 = 0.28; P < 0.001), which in turn correlated significantly with progesterone at OPU + 4 (r2 = 0.32; P < 0.001). LH peaked (4.4 IU/L) 12 h after hCG trigger, persisting for 24 h but was barely elevated compared with physiological levels. Serum estradiol peaked twice: at 24 h post-trigger and at OPU + 4. Highest hCG levels (130 mIU/mL) occurred at 24 h post-injection. The best correlations between the number of follicles ≥11 mm and serum progesterone level were seen at 24 and 36 h after hCG and OPU + 1. LIMITATIONS, REASONS FOR CAUTION: The influence of different profiles of serum progesterone on reproductive outcomes could not be determined because a freeze-all strategy was used in all patients. In addition, data were not available to relate serum hormone level findings with endometrial histology or endometrial receptivity analysis to clearly identify the relationship between serum hormones and the window of implantation. WIDER IMPLICATIONS OF THE FINDINGS: Detailed information about early luteal phase hormone levels could be used to optimize and individualize luteal phase support to improve reproductive outcomes. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by My Duc Hospital, Ho Chi Minh City, Vietnam. All authors state that they have no conflicts of interest to disclose. TRIAL REGISTRATION NUMBER: NCT02798146; NCT03174691.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Vuong LN, Ho TM, Pham TD, et al. The early luteal hormonal profile in IVF patients triggered with hCG. Hum Reprod. 2020. PMID: 31967304. doi:10.1093/humrep/dez235

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。